Clinical trials
Patient Activation clinical trials
Below are recruiting patient activation clinical trials, each written for real people, not researchers. We’re tracking 425 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07053059RecruitingPhase 2
CAR T-cell therapy to prevent relapse in high-risk B-cell ALL
This trial tests a new CAR T-cell therapy (obecabtagene autoleucel) given as a consolidation treatment after initial remission to prevent relapse in people with high-risk B-cell ALL. It's for patients who have achieved first remission but still have high-risk features in their leukemia.
Houston, TexasAges 18 years+ - NCT06832306Recruiting
Diaphragm pacing for breathing support in ICU
This trial tests a device that helps stimulate the diaphragm to improve breathing in patients who need a ventilator. It's for people with new breathing problems who have been in the ICU on a ventilator for less than 4 days.
La Jolla, CaliforniaAges 18 years+ - NCT06819930Enrolling by invitation
Fibromyalgia fitness study for women aged 30-64
This study measures the functional capacity (daily movement and activity) of women with fibromyalgia compared to women without the condition. It helps understand how fibromyalgia affects physical fitness.
Barcelona, BarcelonaAges 30–64 - NCT05413616Recruiting
Personalized nutrition and activity therapy for older hospital patients
This study tests whether a tailored nutrition plan plus a step-by-step exercise program can improve physical strength and performance in older adults in the hospital. It compares these interventions to the usual hospital care you would normally get.
Nijmegen, GelderlandAges 65 years+ - NCT06730477Enrolling by invitation
How well do targeted drugs work for EGFR lung cancer?
This trial studies whether changes in tiny particles in your blood (called exosomes) can show how well targeted therapy is working for lung cancer with an EGFR mutation. You may be eligible if you have this type of lung cancer and are starting your first treatment with a targeted drug.
Wuhan, HubeiAges 18–80 - NCT06287229RecruitingPhase 1/Phase 2
CAR T therapy for B-cell ALL after initial treatment
This trial tests whether a special immune cell therapy (brexucabtagene autoleucel, or CAR T therapy) can help people with B-cell acute lymphocytic leukemia (ALL) after reducing the number of leukemia cells with a chemo-immunotherapy combination. It is for patients whose cancer has returned or is hard to treat, or for those newly diagnosed with a high-risk form of ALL.
Houston, TexasAges 18 years+ - NCT05739565Recruiting
Peer-supported exercise program for men with prostate cancer
This trial tests whether a structured physical activity plan, supported by peers (other participants), can help men with prostate cancer who are currently not very active. It aims to improve motivation and make it easier to exercise safely.
ChambéryAges 18 years+ - NCT04716322Recruiting
Adapted activity program for chronic health conditions in adults
This study tests a 16-week, tailored physical activity program at Mon Stade for adults with certain long-term health problems. It may help improve health and wellbeing through supervised exercise sessions held twice per week.
ParisAges 18 years+ - NCT05739968Recruiting
Active living program for early bladder cancer patients with their own bladder
This trial tests whether a structured “active-living” program (helping you be more active in daily life) improves outcomes for people newly diagnosed with operable early bladder cancer. It may help with overall health and quality of life while you receive standard bladder cancer care without removing your bladder.
TaipeiAges Any age - NCT06249412Recruiting
Positive pressure breathing device for ALS patients
This trial tests whether a mask that helps you breathe out (positive expiratory pressure) combined with a cough-assist machine (in-exsufflator) improves breathing and coughing in people with ALS who have bulbar symptoms like trouble speaking, swallowing, or drooling.
Le Havre, NormandyAges 18–100 - NCT04790253Recruiting
Check brain radiation timing or frequent MRI scans for SCLC
This study compares two ways to follow and treat small-cell lung cancer in the brain: preventive brain radiation versus close monitoring with MRI scans and treatment only if needed. It may help people avoid unnecessary brain treatment or choose the safer timing strategy.
GrazAges 18 years+ - NCT04549688Recruiting
Active surveillance with focused ultrasound for prostate cancer
This trial studies whether a high-intensity focused ultrasound treatment can help people with localized prostate cancer while still avoiding traditional full-dose treatment for some patients. It may be an option for certain intermediate-risk cases where the cancer is confined to the prostate.
Tønsberg, VestfoldAges 18–80 - NCT07856641Recruiting
Timing of blood thinner shots in trauma patients
This study looks at how the time of day you receive your blood thinner shot affects how well it works in preventing blood clots in the hospital. It may help doctors find the best time to give this medicine to trauma patients.
Houston, TexasAges 18–80 - NCT06703320Recruiting
Virtual reality pathfinding study for stroke recovery
This study uses a virtual reality pathfinding game to see how your brain activates after a stroke. It may help doctors understand how to improve recovery.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT06832033Recruiting
Exercise program after atrial fibrillation ablation
This trial is testing whether a structured exercise program (combining cardio and strength training) can help people who have already had a procedure to treat atrial fibrillation. It aims to see if this type of training can improve heart health and quality of life.
Zaragoza, ZaragozaAges 18 years+ - NCT06995742Recruiting
Effect of a vital sign device on staff workload
This study tests whether using a special device (ANNE One-Wellue) to monitor vital signs reduces how often hospital staff need to take measurements manually. It is for patients staying on a specific hospital unit.
Chicago, IllinoisAges 18 years+ - NCT06914245Recruiting
Personalized help for bowel symptoms after rectal cancer treatment
This trial studies how to improve bowel symptoms in people treated for rectal cancer. It tests personalized care plans and looks at different factors that may contribute to bowel problems after surgery or a watch-and-wait approach.
Leuven, Vlaams-BrabantAges 18 years+ - NCT06863376RecruitingPhase 2
Carbocisteine for fatty liver disease: safety and benefit study
This study tests a medicine called carbocisteine to see if it can help treat nonalcoholic fatty liver disease (NAFLD). If you have a fatty liver and no other liver or kidney conditions, this trial may explore whether this drug is safe and effective for you.
TantaAges 18–65 - NCT06002022Recruiting
How hormone therapy affects your quality of life
This study looks at how hormone therapy affects your quality of life. You'll answer questionnaires about your symptoms and well-being over time.
ValenciaAges 18–75 - NCT06689111Recruiting
Heart resynchronization method study for patients with LBBB and heart failure
This study compares two ways to resynchronize the heart's pumping in people with heart failure and a specific heart block (LBBB). It uses special ultrasound imaging to see which method works better for improving heart function.
Pátrai, GreeceAges 18–90 - NCT06624189Enrolling by invitation
Liver cancer screening decision support for cirrhosis patients
This trial tests a tool to help doctors and patients decide when to screen for liver cancer. It is for people with cirrhosis who have not had imaging in the last 6 months.
New York, New YorkAges 18 years+ - NCT06191978RecruitingPhase 1
Testing venetoclax with decitabine/cedazuridine for pediatric AML
This trial tests a combination of two oral drugs (venetoclax and decitabine/cedazuridine) for children and teens whose acute myeloid leukemia (AML) has returned or not improved after prior treatment. The goal is to find a safe dose and see if the drugs can help shrink or control the leukemia.
Houston, TexasAges 2–18 - NCT05211401RecruitingPhase 2
Testing rituximab for heart attack patients
This study tests whether adding the drug rituximab to standard heart attack treatment can reduce damage to the heart muscle after a heart attack. Rituximab is usually used for immune system conditions, and it may help calm inflammation and protect the heart. Participants must have a certain type of heart attack and be treated quickly.
ParisAges 18 years+ - NCT05061576Recruiting
At-home exercise program for people with liver scarring
This study tests an at-home, guided physical exercise plan for people with liver cirrhosis. It may help improve strength and day-to-day functioning while monitoring safety.
StockholmAges 18 years+
Hear when a new Patient Activation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient activation?
- Yes. Clin2 currently lists 425 recruiting patient activation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient activation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient activation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.